Dongin (Donoven) Kim, Ph.D.
Prof,Asst
Pharmaceutical Sciences
Phone (405) 271-6593 x 47473
Office COP200
Email dongin-kim@ou.edu
Publications & Presentations
- 56. Lee E S, Oh K T, Kim D, Youn Y S, Bae Y H. Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine). Journal of controlled release : official journal of the Controlled Release Society. 2007; 123 : 19-26
57. Kim D, El-Shall H, Dennis D, Morey T. Interaction of PLGA nanoparticles with human blood constituents Authors. Colloids and Surfaces B: Biointerfaces. 2004; 40 : 83-91
Grants
- 6. Lymphatics and lymphangiogenesis in kidney function and inflammation. NIH. Start Date: 2019. End Date: 2024.
7. Extracellular Vesicle Therapy for Diabetic Retinopathy. NEI. Start Date: 2023. End Date: 2024.
8. Preclinical assessment of exosomal drug delivery system using innovative tumor mouse model. Misc Non-Federal. Start Date: 2024. End Date: 2024.
9. Role of Renal Lymphatics in Blood Pressure Regulation. NIH. Start Date: 2018. End Date: 2023.
10. Cancer exosome mediated antibody production for active tumor targeting treatment. Non-federal. Start Date: 2022. End Date: 2023.
Awards and Honors
no results
Education
- 1. Degree: Ph D. University of Utah. Date: 2009.
2. Degree: MS. University of Florida. Date: 2002.
3. Degree: BS. Ajou University. Date: 1999.
Administrative Assignments
no results